[1] Siegel R, Ma J, Zou Z, et al.Cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64(1):9-29. [2] Jemal A, Bray F, Center MM, et al.Global cancer statistics[J]. Cancer J Clin, 2011, 61:69-90. [3] Chen W, Zheng R, Zuo T, et al.National cancer incidence and mortality in China, 2012[J]. Chin J Cancer Res, 2016, 28(1):1-11. [4] Yang L, Yang J, Li J, et al.MircoRNA-33a inhibits epithelial-to-mesenchymal transition and?metastasis?and could be a prognostic marker in non-small cell?lung cancer[J]. Sci Rep, 2015(5):13677. [5] Hsu YL, Hung JY, Liang YY, et al.S100P interacts with integrin 〈7 and increases cancer cell migration and invasion in lung cancer[J]. Oncotarget, 2015, 6(30):29585-29598. [6] Mongre RK, Sodhi SS, Sharma N, et al.Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in axenograft model of lung adenocarcinoma[J]. Int J Oncol, 2016, 48(1):84-98. [7] Jia D, Yan M, Wang X, et al.Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion[J]. BMC Cancer, 2010(10):364. [8] 薛强, 屈谦, 杜永洪, 等. 兔VX2肺癌模型的建立及生物学特性观察[J]. 中华实用外科杂志, 2001, 18(5):478. [9] 魏淑珍, 孙宇, 杨志坚, 等. EGFP标记的人肺癌裸鼠原位移植模型的建立[J]. 中国肺癌杂志, 2010, 13(7):670-675. [10] 王晓敏, 闫明霞, 梁琳慧, 等. GFP和Luc双标技术在小鼠肿瘤模型建立中的应用[J]. 实验动物与比较医学, 2010,30(1):2-7. |